PMBPX Performance — MidCap Fund, Class R-5
Data updated: 2026-09-25
PMBPX returned −4.55% year to date and −9.21% over one year to Jul 2026. Annualised returns are +7.74% over 3 years and +3.52% over 5 years. The fund trailed its US Mid-Cap Blend category average: $100 invested three years ago grew to $125, against $144 for the category, and to $91 over one year, against $119. Volatility over the past three years was 15.15% a year. In the 12 months to Jul 2026 the fund lost a net $4.7B, and assets reached $23.10B.
PMBPX Growth of $100
What $100 invested in MidCap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Blend category average over the same months.
| Period | PMBPX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $91 | $119 |
| 3 years (Aug 2023 – Jul 2026) | $125 | $144 |
| 5 years (Aug 2021 – Jul 2026) | $119 | $145 |
| Since data start (Aug 2019 – Jul 2026) | $178 | $204 |
PMBPX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −4.55% |
| 1 year | −9.21% |
| 3 years (annualised) | +7.74% |
| 5 years (annualised) | +3.52% |
PMBPX Annual Returns
Calendar-year total returns of MidCap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −4.55% |
| 2025 | +1.44% |
| 2024 | +19.79% |
| 2023 | +25.64% |
| 2022 | −23.27% |
| 2021 | +25.07% |
| 2020 | +18.05% |
| 2019 (Aug–Dec) | +7.62% |
PMBPX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.7% | −3.2% | −7.6% | +3.6% | +0.7% | +2.0% | +0.9% | — | — | — | — | — |
| 2025 | +5.2% | −1.2% | −4.2% | −0.5% | +3.8% | +2.8% | +0.9% | +0.7% | −1.5% | −4.2% | +1.2% | −1.1% |
| 2024 | +1.1% | +5.7% | +3.8% | −6.3% | +3.4% | +0.4% | +6.3% | +1.8% | +2.4% | −0.9% | +9.0% | −7.3% |
| 2023 | +8.4% | −3.0% | +0.3% | +2.1% | −0.8% | +8.2% | +0.8% | −0.9% | −5.2% | −3.3% | +12.5% | +5.5% |
| 2022 | −10.6% | −3.8% | +2.7% | −8.7% | −0.7% | −8.4% | +11.1% | −3.9% | −9.3% | +7.1% | +7.5% | −6.2% |
| 2021 | −4.4% | +5.9% | +2.2% | +6.5% | +0.4% | +2.2% | +4.1% | +0.4% | −3.7% | +7.5% | −3.1% | +5.6% |
| 2020 | +3.3% | −7.0% | −20.8% | +13.2% | +9.0% | +1.1% | +6.1% | +4.3% | −2.3% | −2.2% | +12.8% | +4.2% |
| 2019 | — | — | — | — | — | — | — | +0.6% | +0.8% | +1.6% | +3.1% | +1.3% |
PMBPX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 15.15%
- 3-year Sharpe ratio: 0.21 (vs 4.5% risk-free rate)
- Best month: +12.50% (Nov 2023)
- Worst month: −7.59% (Mar 2026)
PMBPX Fund Flows
Monthly money in and out of MidCap Fund, from SEC Form N-PORT.
- 12-month net flow: −$4.7B
- 12-month gross sales (incl. reinvestments): $8.0B
- Sales ÷ redemptions: 0.63×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $246.2M | $1.2B | −$989.6M |
| Jun 2026 | $267.5M | $1.4B | −$1.1B |
| May 2026 | $626.4M | $1.4B | −$808.6M |
| Apr 2026 | $398.0M | $1.4B | −$1.0B |
| Mar 2026 | $450.0M | $1.9B | −$1.4B |
| Feb 2026 | $540.4M | $990.8M | −$450.4M |
| Jan 2026 | $664.8M | $841.3M | −$176.5M |
| Dec 2025 | $2.1B | $1.1B | $927.6M |
| Nov 2025 | $495.6M | $697.7M | −$202.1M |
| Oct 2025 | $623.8M | $831.2M | −$207.4M |
| Sep 2025 | $922.7M | $371.0M | $551.8M |
| Aug 2025 | $669.0M | $403.0M | $266.0M |
PMBPX Assets Under Management
Net assets of MidCap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $23.10B |
| 2026-04-30 | $25.19B |
| 2026-01-31 | $30.25B |
| 2025-10-31 | $31.58B |
| 2025-07-31 | $32.61B |
| 2025-04-30 | $29.49B |
| 2025-01-31 | $30.41B |
| 2024-10-31 | $28.09B |
| 2024-07-31 | $26.19B |
| 2024-04-30 | $23.04B |
| 2024-01-31 | $21.98B |
| 2023-10-31 | $18.22B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.